FDA Inspection 1012914 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on May 4, 2017 in Ronkonkoma, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ronkonkoma, NY (United States)